US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TriSalus Life Sciences Inc.

3.86

-0.1500-3.74%

Volume:117.29K

Turnover:458.40K

Market Cap:236.64M

PE:-2.10

High:4.00

Open:4.00

Low:3.81

Close:4.01

52wk High:7.95

52wk Low:3.42

Shares:61.31M

Float Shares:51.36M

Volume Ratio:0.79

T/O Rate:0.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8389

EPS(LYR):-1.8389

ROE:-496.21%

ROA:-56.80%

PB:-6.99

PE(LYR):-2.10

Loading ...

Overview Company News Filings

TriSalus Life Sciences price target lowered to $8 from $12.50 at Northland

TriSalus Life Sciences reports preclinical study of PEDD-delivered nelitolimod in liver tumor models

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE)

TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity

TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity

TriSalus Life Sciences Publishes Investor Presentation on Pressure-Enabled Drug Delivery for Solid Tumors

TriSalus Life Sciences price target lowered to $7 from $12 at Canaccord

TriSalus posts Q4 revenue of USD 13.2 million up 60%

TriSalus Life Sciences Q4 Income From Operations USD -3.271 Million

THOMSON REUTERS

Press Release: TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance

TriSalus Life Sciences Inc expected to post a loss of 13 cents a share - Earnings Preview

Lake Street Sticks to Its Buy Rating for TriSalus Life Sciences (TLSI)

TriSalus Life Sciences Inc. to Host Fourth Quarter Financial Results Conference Call

Lake Street Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)

TriSalus Life Sciences Director Michael P Stansky Acquires Common Shares

TriSalus Life Sciences Prices Stock Offering at $4.10 a Share

MT Newswires Live

TriSalus Life Sciences Inc - Prices Public Offering at $4.10 per Share

THOMSON REUTERS

TriSalus Life Sciences Proposes Public Offering

THOMSON REUTERS

TriSalus Life Sciences Inc. Files Initial Statement of Beneficial Ownership for Director Michael P. Stansky

BRIEF-Trisalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky To Its Board Of Directors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TLSI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLSI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLSI\",,,,,undefined,":{"symbol":"TLSI","market":"US","secType":"STK","nameCN":"TriSalus Life Sciences Inc.","latestPrice":3.86,"timestamp":1774546727126,"preClose":4.01,"halted":0,"volume":117288,"delay":0,"changeRate":-0.03740648379052367,"floatShares":51362000,"shares":61306437,"eps":-1.838893,"marketStatus":"Trading","change":-0.15,"latestTime":"03-26 13:39:30 EDT","open":4,"high":4,"low":3.81,"amount":458397.66389039997,"amplitude":0.047382,"askPrice":3.89,"askSize":380,"bidPrice":3.86,"bidSize":195,"shortable":3,"etf":0,"ttmEps":-1.838893,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774555200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":4.01,"postHourTrading":{"tag":"盘后","latestPrice":4.01,"preClose":4.01,"latestTime":"16:10 EDT","volume":712,"amount":2855.12,"timestamp":1774469405243,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.786811},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLSI\",,,,,undefined,":{"symbol":"TLSI","floatShares":51362000,"roa":"-56.80%","roe":"-496.21%","lyrEps":-1.838893,"volumeRatio":0.786811,"shares":61306437,"dividePrice":0,"high":4,"amplitude":0.047382,"preClose":4.01,"low":3.81,"week52Low":3.42,"pbRate":"-6.99","psRate":"5.24","week52High":7.95,"institutionHeld":0,"latestPrice":3.86,"committee":-0.321739,"eps":-1.838893,"divideRate":0,"volume":117288,"delay":0,"ttmEps":-1.838893,"open":4,"prevYearClose":6.98,"prevWeekClose":3.93,"prevMonthClose":5.06,"prevQuarterClose":6.98,"fiveDayClose":3.86,"twentyDayClose":5.38,"sixtyDayClose":6.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLSI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-05","symbol":"TLSI","fiscalQuarterEnding":"2025/12","expectedEps":-0.13,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2026-01-12","symbol":"TLSI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-11-13","symbol":"TLSI","fiscalQuarterEnding":"2025/09","expectedEps":-0.17,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.96},{"market":"US","date":"2025-08-12","symbol":"TLSI","fiscalQuarterEnding":"2025/06","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2025-05-15","symbol":"TLSI","fiscalQuarterEnding":"2025/03","expectedEps":-0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLSI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLSI\",market:\"US\",delay:true,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":5,"updateTime":1739505600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLSI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"TLSI","date":"2026-03-25","current":-2.18066,"percent":0.311005,"low":-9.467241,"twenty":-7.049443,"median":-4.695429,"eighty":-2.514756,"high":-1.950969,"avg":-4.767048,"sd":2.126685,"marketCap":238482039},"quantilePoints":[{"date":"2023-08-25","current":-3.951708,"twenty":-4.696261,"median":-4.538989,"eighty":-4.36181,"marketCap":208954447},{"date":"2023-09-01","current":-3.244979,"twenty":-4.556906,"median":-3.745164,"eighty":-3.316647,"marketCap":171584760},{"date":"2023-09-08","current":-2.543227,"twenty":-4.494197,"median":-3.351984,"eighty":-2.924463,"marketCap":134478239},{"date":"2023-09-15","current":-2.351614,"twenty":-4.156759,"median":-3.040924,"eighty":-2.399891,"marketCap":124346317},{"date":"2023-09-22","current":-2.782122,"twenty":-3.703855,"median":-2.807006,"eighty":-2.468573,"marketCap":147110246},{"date":"2023-09-29","current":-2.672628,"twenty":-3.43709,"median":-2.737329,"eighty":-2.513366,"marketCap":141320576},{"date":"2023-10-06","current":-2.418803,"twenty":-3.3485,"median":-2.63779,"eighty":-2.507394,"marketCap":127899069},{"date":"2023-10-13","current":-2.478527,"twenty":-3.280813,"median":-2.558158,"eighty":-2.463596,"marketCap":131057071},{"date":"2023-10-20","current":-2.378988,"twenty":-3.122546,"median":-2.540739,"eighty":-2.438711,"marketCap":125793735},{"date":"2023-10-27","current":-2.364057,"twenty":-3.040924,"median":-2.535762,"eighty":-2.42378,"marketCap":125004234},{"date":"2023-11-03","current":-2.045531,"twenty":-3.016039,"median":-2.52332,"eighty":-2.378988,"marketCap":108161558},{"date":"2023-11-10","current":-1.950969,"twenty":-2.826914,"median":-2.488481,"eighty":-2.324241,"marketCap":103161389},{"date":"2023-11-17","current":-2.256319,"twenty":-2.787099,"median":-2.463596,"eighty":-2.289402,"marketCap":103950889},{"date":"2023-11-24","current":-2.28488,"twenty":-2.783117,"median":-2.463596,"eighty":-2.279168,"marketCap":105266724},{"date":"2023-12-01","current":-2.28488,"twenty":-2.746288,"median":-2.438711,"eighty":-2.28031,"marketCap":105266724},{"date":"2023-12-08","current":-2.267744,"twenty":-2.737329,"median":-2.418803,"eighty":-2.260889,"marketCap":104477223},{"date":"2023-12-15","current":-4.5412,"twenty":-2.795062,"median":-2.431246,"eighty":-2.266602,"marketCap":209217613},{"date":"2023-12-22","current":-4.598322,"twenty":-3.021016,"median":-2.448665,"eighty":-2.281453,"marketCap":211849282},{"date":"2023-12-29","current":-4.95819,"twenty":-3.29873,"median":-2.463596,"eighty":-2.28488,"marketCap":228428791},{"date":"2024-01-05","current":-4.758263,"twenty":-3.39876,"median":-2.463596,"eighty":-2.28488,"marketCap":219217952},{"date":"2024-01-12","current":-5.032449,"twenty":-4.524063,"median":-2.488481,"eighty":-2.28488,"marketCap":231849959},{"date":"2024-01-19","current":-4.741127,"twenty":-4.602892,"median":-2.518343,"eighty":-2.28488,"marketCap":218428452},{"date":"2024-01-26","current":-5.146693,"twenty":-4.685148,"median":-2.533274,"eighty":-2.28488,"marketCap":237113295},{"date":"2024-02-02","current":-5.072434,"twenty":-4.83138,"median":-2.545716,"eighty":-2.28488,"marketCap":233692127},{"date":"2024-02-09","current":-5.489425,"twenty":-4.967529,"median":-2.592997,"eighty":-2.28488,"marketCap":252903304},{"date":"2024-02-16","current":-5.472288,"twenty":-5.007315,"median":-2.704979,"eighty":-2.288498,"marketCap":252113803},{"date":"2024-02-23","current":-5.340908,"twenty":-5.041589,"median":-2.759726,"eighty":-2.289402,"marketCap":246060967},{"date":"2024-03-01","current":-5.44944,"twenty":-5.138125,"median":-2.826914,"eighty":-2.290117,"marketCap":251061136},{"date":"2024-03-08","current":-5.50085,"twenty":-5.175254,"median":-2.964631,"eighty":-2.290593,"marketCap":253429638},{"date":"2024-03-15","current":-5.318059,"twenty":-5.209527,"median":-3.244979,"eighty":-2.301823,"marketCap":245008300},{"date":"2024-03-22","current":-5.409454,"twenty":-5.259795,"median":-3.384081,"eighty":-2.31379,"marketCap":249218969},{"date":"2024-03-28","current":-5.392318,"twenty":-5.294068,"median":-3.745164,"eighty":-2.319762,"marketCap":248429468},{"date":"2024-04-05","current":-4.384474,"twenty":-5.294068,"median":-4.384474,"eighty":-2.326776,"marketCap":258850575},{"date":"2024-04-12","current":-4.353156,"twenty":-5.276931,"median":-4.384474,"eighty":-2.338992,"marketCap":257001642},{"date":"2024-04-19","current":-4.455335,"twenty":-5.266649,"median":-4.384474,"eighty":-2.356591,"marketCap":263034039},{"date":"2024-04-26","current":-4.500658,"twenty":-5.262079,"median":-4.384474,"eighty":-2.364057,"marketCap":265709869},{"date":"2024-05-03","current":-4.233248,"twenty":-5.243801,"median":-4.375526,"eighty":-2.370029,"marketCap":249922475},{"date":"2024-05-10","current":-4.441737,"twenty":-5.217524,"median":-4.376905,"eighty":-2.392923,"marketCap":262231291},{"date":"2024-05-17","current":-4.056251,"twenty":-5.20153,"median":-4.378284,"eighty":-2.413826,"marketCap":259555461},{"date":"2024-05-24","current":-3.989344,"twenty":-5.198103,"median":-4.360154,"eighty":-2.415817,"marketCap":255274134},{"date":"2024-05-31","current":-3.157814,"twenty":-5.195818,"median":-4.356655,"eighty":-2.419798,"marketCap":202065392},{"date":"2024-06-07","current":-2.937107,"twenty":-5.185536,"median":-4.305766,"eighty":-2.426766,"marketCap":187942542},{"date":"2024-06-14","current":-2.47447,"twenty":-5.180966,"median":-4.244579,"eighty":-2.438711,"marketCap":158338876},{"date":"2024-06-21","current":-2.410805,"twenty":-5.176396,"median":-4.23778,"eighty":-2.426982,"marketCap":154264977},{"date":"2024-06-28","current":-2.44476,"twenty":-5.175254,"median":-4.233248,"eighty":-2.429968,"marketCap":156437723},{"date":"2024-07-05","current":-2.534093,"twenty":-5.175254,"median":-4.21965,"eighty":-2.42378,"marketCap":162154099},{"date":"2024-07-12","current":-2.451758,"twenty":-5.16383,"median":-4.144067,"eighty":-2.427782,"marketCap":156885554},{"date":"2024-07-15","current":-2.470055,"twenty":-5.161545,"median":-4.118977,"eighty":-2.428003,"marketCap":158056342},{"date":"2024-08-02","current":-2.653034,"twenty":-5.15926,"median":-4.087614,"eighty":-2.428224,"marketCap":169765008},{"date":"2024-08-09","current":-2.59357,"twenty":-5.15012,"median":-3.989344,"eighty":-2.432817,"marketCap":165959930},{"date":"2024-08-16","current":-3.172195,"twenty":-5.140981,"median":-3.732619,"eighty":-2.438711,"marketCap":172399292},{"date":"2024-08-23","current":-3.014909,"twenty":-5.128985,"median":-3.369403,"eighty":-2.441131,"marketCap":163851273},{"date":"2024-08-30","current":-2.82614,"twenty":-5.10328,"median":-3.274262,"eighty":-2.446322,"marketCap":153592249},{"date":"2024-09-06","current":-2.815354,"twenty":-5.069007,"median":-3.175616,"eighty":-2.448733,"marketCap":153006019},{"date":"2024-09-13","current":-2.772206,"twenty":-5.050728,"median":-3.157814,"eighty":-2.449555,"marketCap":150661099},{"date":"2024-09-20","current":-2.475569,"twenty":-5.030164,"median":-3.120622,"eighty":-2.449555,"marketCap":134539775},{"date":"2024-09-27","current":-2.249047,"twenty":-5.021025,"median":-3.067173,"eighty":-2.438711,"marketCap":122228946},{"date":"2024-10-04","current":-2.324554,"twenty":-5.017598,"median":-3.038972,"eighty":-2.428003,"marketCap":126332556},{"date":"2024-10-11","current":-2.286801,"twenty":-5.002746,"median":-3.016039,"eighty":-2.416754,"marketCap":124280751},{"date":"2024-10-18","current":-2.292194,"twenty":-4.992464,"median":-2.998729,"eighty":-2.411409,"marketCap":124573866},{"date":"2024-10-25","current":-2.216686,"twenty":-4.969615,"median":-2.913222,"eighty":-2.395748,"marketCap":120470256},{"date":"2024-10-31","current":-2.232956,"twenty":-4.969615,"median":-2.861813,"eighty":-2.364057,"marketCap":121354466},{"date":"2024-11-08","current":-2.345165,"twenty":-4.967008,"median":-2.826527,"eighty":-2.342895,"marketCap":127452680},{"date":"2024-11-15","current":-2.249787,"twenty":-4.95819,"median":-2.787099,"eighty":-2.342895,"marketCap":122269198},{"date":"2024-11-22","current":-2.44476,"twenty":-4.883932,"median":-2.767647,"eighty":-2.330578,"marketCap":135075448},{"date":"2024-11-29","current":-2.516673,"twenty":-4.856514,"median":-2.737329,"eighty":-2.330452,"marketCap":139048704},{"date":"2024-12-06","current":-2.290393,"twenty":-4.83138,"median":-2.702092,"eighty":-2.324491,"marketCap":126546518},{"date":"2024-12-13","current":-2.191051,"twenty":-4.771972,"median":-2.691305,"eighty":-2.315283,"marketCap":121057753},{"date":"2024-12-20","current":-1.986847,"twenty":-4.744554,"median":-2.685912,"eighty":-2.292194,"marketCap":109775293},{"date":"2024-12-27","current":-2.753991,"twenty":-4.72399,"median":-2.677186,"eighty":-2.292194,"marketCap":152160753},{"date":"2025-01-03","current":-2.748472,"twenty":-4.698857,"median":-2.685912,"eighty":-2.294351,"marketCap":151855822},{"date":"2025-01-10","current":-2.638092,"twenty":-4.676008,"median":-2.685912,"eighty":-2.29946,"marketCap":145757194},{"date":"2025-01-17","current":-2.665687,"twenty":-4.661727,"median":-2.685912,"eighty":-2.307422,"marketCap":147281851},{"date":"2025-01-24","current":-2.847814,"twenty":-4.641162,"median":-2.688608,"eighty":-2.30931,"marketCap":157344586},{"date":"2025-01-31","current":-2.820219,"twenty":-4.641162,"median":-2.696699,"eighty":-2.316776,"marketCap":155819930},{"date":"2025-02-07","current":-2.969233,"twenty":-4.628574,"median":-2.702092,"eighty":-2.317988,"marketCap":164053077},{"date":"2025-02-14","current":-3.052018,"twenty":-4.623033,"median":-2.70432,"eighty":-2.324241,"marketCap":168627047},{"date":"2025-02-21","current":-3.156879,"twenty":-4.621543,"median":-2.737329,"eighty":-2.324491,"marketCap":174420743},{"date":"2025-02-28","current":-3.129284,"twenty":-4.604531,"median":-2.740194,"eighty":-2.328869,"marketCap":172896086},{"date":"2025-03-07","current":-3.123765,"twenty":-4.598732,"median":-2.753991,"eighty":-2.330452,"marketCap":172591155},{"date":"2025-03-14","current":-2.925081,"twenty":-4.588306,"median":-2.764058,"eighty":-2.333271,"marketCap":161613626},{"date":"2025-03-21","current":-2.969233,"twenty":-4.553589,"median":-2.772206,"eighty":-2.33884,"marketCap":164053077},{"date":"2025-03-28","current":-5.579621,"twenty":-4.553589,"median":-2.784611,"eighty":-2.340601,"marketCap":167712253},{"date":"2025-04-04","current":-5.43444,"twenty":-4.621543,"median":-2.8147,"eighty":-2.342463,"marketCap":163277758},{"date":"2025-04-11","current":-5.777997,"twenty":-4.646303,"median":-2.820219,"eighty":-2.344711,"marketCap":173599915},{"date":"2025-04-17","current":-6.154808,"twenty":-4.72399,"median":-2.826527,"eighty":-2.349034,"marketCap":184921207},{"date":"2025-04-25","current":-6.068877,"twenty":-4.863368,"median":-2.842295,"eighty":-2.35908,"marketCap":182339410},{"date":"2025-05-02","current":-5.46736,"twenty":-4.969615,"median":-2.847814,"eighty":-2.364057,"marketCap":164266831},{"date":"2025-05-09","current":-5.574774,"twenty":-5.021025,"median":-2.861813,"eighty":-2.369553,"marketCap":167494077},{"date":"2025-05-16","current":-6.059832,"twenty":-5.092998,"median":-2.908113,"eighty":-2.37668,"marketCap":164912280},{"date":"2025-05-23","current":-6.344443,"twenty":-5.156975,"median":-2.925081,"eighty":-2.381924,"marketCap":172657671},{"date":"2025-05-30","current":-6.498607,"twenty":-5.178681,"median":-2.925081,"eighty":-2.384016,"marketCap":176853091},{"date":"2025-06-06","current":-7.424857,"twenty":-5.20153,"median":-2.941638,"eighty":-2.388398,"marketCap":202060057},{"date":"2025-06-13","current":-7.647325,"twenty":-5.265299,"median":-2.958195,"eighty":-2.396826,"marketCap":208114291},{"date":"2025-06-20","current":-7.480474,"twenty":-5.297495,"median":-2.969233,"eighty":-2.400062,"marketCap":203573615},{"date":"2025-06-27","current":-7.049443,"twenty":-5.323771,"median":-3.012212,"eighty":-2.401141,"marketCap":191843537},{"date":"2025-07-03","current":-7.049443,"twenty":-5.34662,"median":-3.022216,"eighty":-2.405455,"marketCap":191843537},{"date":"2025-07-11","current":-6.952113,"twenty":-5.392318,"median":-3.038972,"eighty":-2.410805,"marketCap":189194810},{"date":"2025-07-18","current":-6.562795,"twenty":-5.426591,"median":-3.04374,"eighty":-2.413826,"marketCap":178599900},{"date":"2025-07-25","current":-6.493274,"twenty":-5.44944,"median":-3.063056,"eighty":-2.413826,"marketCap":176707952},{"date":"2025-08-01","current":-5.881488,"twenty":-5.488843,"median":-3.076854,"eighty":-2.416242,"marketCap":160058809},{"date":"2025-08-08","current":-5.102851,"twenty":-5.492169,"median":-3.085132,"eighty":-2.418803,"marketCap":138868990},{"date":"2025-08-15","current":-6.207412,"twenty":-5.50085,"median":-3.104761,"eighty":-2.421636,"marketCap":193485042},{"date":"2025-08-22","current":-7.935249,"twenty":-5.546547,"median":-3.118246,"eighty":-2.42378,"marketCap":247341703},{"date":"2025-08-29","current":-8.175226,"twenty":-5.569396,"median":-3.121005,"eighty":-2.427782,"marketCap":254821795},{"date":"2025-09-05","current":-8.23922,"twenty":-5.585719,"median":-3.126572,"eighty":-2.428666,"marketCap":256816486},{"date":"2025-09-12","current":-7.487291,"twenty":-5.660791,"median":-3.136277,"eighty":-2.43603,"marketCap":233378865},{"date":"2025-09-19","current":-7.871255,"twenty":-5.725943,"median":-3.15136,"eighty":-2.438532,"marketCap":245347012},{"date":"2025-09-26","current":-7.615279,"twenty":-5.748846,"median":-3.157814,"eighty":-2.438711,"marketCap":237368248},{"date":"2025-10-03","current":-7.231315,"twenty":-5.817463,"median":-3.172816,"eighty":-2.44355,"marketCap":225400101},{"date":"2025-10-10","current":-7.071331,"twenty":-5.859241,"median":-3.179036,"eighty":-2.44476,"marketCap":220413373},{"date":"2025-10-17","current":-7.599281,"twenty":-6.061641,"median":-3.274262,"eighty":-2.447884,"marketCap":236869575},{"date":"2025-10-24","current":-8.207223,"twenty":-6.143089,"median":-3.369403,"eighty":-2.448936,"marketCap":255819141},{"date":"2025-10-31","current":-7.471293,"twenty":-6.154808,"median":-3.732619,"eighty":-2.451207,"marketCap":232880192},{"date":"2025-11-07","current":-7.023335,"twenty":-6.21731,"median":-3.989344,"eighty":-2.453548,"marketCap":218917354},{"date":"2025-11-14","current":-7.037001,"twenty":-6.34115,"median":-4.087614,"eighty":-2.461676,"marketCap":219343325},{"date":"2025-11-21","current":-6.261002,"twenty":-6.329204,"median":-4.218938,"eighty":-2.463596,"marketCap":247822982},{"date":"2025-11-28","current":-8.671993,"twenty":-6.359803,"median":-4.21965,"eighty":-2.463596,"marketCap":343254816},{"date":"2025-12-05","current":-8.457402,"twenty":-6.420382,"median":-4.241104,"eighty":-2.467471,"marketCap":334760883},{"date":"2025-12-12","current":-9.467241,"twenty":-6.540548,"median":-4.301233,"eighty":-2.472152,"marketCap":374732332},{"date":"2025-12-19","current":-9.189535,"twenty":-6.598221,"median":-4.346445,"eighty":-2.474102,"marketCap":363740184},{"date":"2025-12-26","current":-8.911829,"twenty":-6.831175,"median":-4.360154,"eighty":-2.47491,"marketCap":352748035},{"date":"2026-01-02","current":-8.810846,"twenty":-6.921713,"median":-4.36784,"eighty":-2.476161,"marketCap":348750890},{"date":"2026-01-09","current":-7.750515,"twenty":-6.963236,"median":-4.384474,"eighty":-2.480093,"marketCap":306780869},{"date":"2026-01-16","current":-7.763138,"twenty":-7.034268,"median":-4.384474,"eighty":-2.487435,"marketCap":307280512},{"date":"2026-01-23","current":-6.93002,"twenty":-7.023335,"median":-4.403212,"eighty":-2.49175,"marketCap":274304067},{"date":"2026-01-30","current":-6.298871,"twenty":-7.023335,"median":-4.455335,"eighty":-2.492926,"marketCap":249321911},{"date":"2026-02-06","current":-5.907558,"twenty":-7.005758,"median":-4.462101,"eighty":-2.498435,"marketCap":233832975},{"date":"2026-02-13","current":-6.021165,"twenty":-6.980512,"median":-4.524063,"eighty":-2.502257,"marketCap":238329763},{"date":"2026-02-20","current":-5.829817,"twenty":-6.975463,"median":-4.5412,"eighty":-2.50255,"marketCap":230755808},{"date":"2026-02-27","current":-8.129613,"twenty":-7.026068,"median":-4.592062,"eighty":-2.510661,"marketCap":321786354},{"date":"2026-03-06","current":-7.454858,"twenty":-7.053821,"median":-4.621171,"eighty":-2.513192,"marketCap":292431704},{"date":"2026-03-13","current":-6.407739,"twenty":-7.053821,"median":-4.634868,"eighty":-2.513357,"marketCap":251356391},{"date":"2026-03-20","current":-6.032652,"twenty":-7.049443,"median":-4.666868,"eighty":-2.513456,"marketCap":236642846},{"date":"2026-03-25","current":-6.079538,"twenty":-7.049443,"median":-4.695429,"eighty":-2.514756,"marketCap":238482039}],"updateTime":1774516950600},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLSI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621709365","title":"TriSalus Life Sciences price target lowered to $8 from $12.50 at Northland","url":"https://stock-news.laohu8.com/highlight/detail?id=2621709365","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621709365?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:17","pubTimestamp":1774271860,"startTime":"0","endTime":"0","summary":"Northland analyst Carl Byrnes lowered the firm’s price target on TriSalus Life Sciences (TLSI) to $8 from $12.50 and keeps an Outperform rating on ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trisalus-life-sciences-price-target-lowered-to-8-from-12-50-at-northland-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trisalus-life-sciences-price-target-lowered-to-8-from-12-50-at-northland-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2620025382","title":"TriSalus Life Sciences reports preclinical study of PEDD-delivered nelitolimod in liver tumor models","url":"https://stock-news.laohu8.com/highlight/detail?id=2620025382","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620025382?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:02","pubTimestamp":1773835371,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences announced the publication of a preclinical study in Frontiers in Oncology evaluating pressure-enabled drug delivery  of nelitolimod, an investigational TLR9 agonist, in liver tumor models. The study compared PEDD delivery using the TriNav Infusion System versus conventional microcatheter delivery in a porcine hepatic tumor model, and also assessed anti-tumor activity in murine liver metastasis models. Results have already been presented in the publication and showed greater distribution of nelitolimod within and around tumors with PEDD compared with a conventional microcatheter. The study also reported reduced myeloid-derived suppressor cells and increased CD8+ T-cell infiltration in the tumor microenvironment following PEDD delivery. In the murine model, nelitolimod delivered with PEDD reduced tumor growth compared with systemic administration at key study time points.Disclaimer: This news brief was created by Public Technologies  using generative artificial int","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL329kFq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2618203957","title":"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618203957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618203957?lang=en_us&edition=fundamental","pubTime":"2026-03-11 00:50","pubTimestamp":1773161405,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on TriSalus Life Sciences (TLSI – Research Report), Cullinan Managem...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-cullinan-management-cgem-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-cullinan-management-cgem-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234572021.USD","SG9999002224.SGD","LU0122379950.USD","LU0058720904.USD","LU0029874061.USD","BK4588","IE00BBT3K403.USD","SG9999001176.SGD","LU0985481810.HKD","SG9999003800.SGD","CGEM","LU0456855351.SGD","BK4581","LU0289739699.SGD","LU0225284248.USD","BK4137","LU0128526141.USD","IE00B19Z3581.USD","SG9999001176.USD","IE00BLSP4452.SGD","BK4007","SG9999013999.USD","SGXZ57979304.SGD","LABU","LU0868494617.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1894683264.USD","PFE","IE00BLSP4239.USD","LU0321505868.SGD","IE000M9KFDE8.USD","LU0306807586.USD","LU1883839398.USD","BK4139","LU0225771236.USD","LU0170899867.USD","LU1894683348.USD","BK4592","IE0002270589.USD","BK4568","BK4550","SG9999011175.SGD","BK4585","LU0306806265.USD","BK4599","LU1057294990.SGD","LU1066051498.USD","TLSI","BK4533","LU1023059063.AUD","LU0321505439.SGD","XBI","BK4534","SG9999002232.USD"],"gpt_icon":0},{"id":"2618671401","title":"TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2618671401","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618671401?lang=en_us&edition=fundamental","pubTime":"2026-03-10 03:57","pubTimestamp":1773086220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLSI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 09, 2026 15:57 ET (19:57 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2617637475","title":"TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2617637475","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617637475?lang=en_us&edition=fundamental","pubTime":"2026-03-07 03:38","pubTimestamp":1772825880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLSI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2026 14:38 ET (19:38 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2617631846","title":"TriSalus Life Sciences Publishes Investor Presentation on Pressure-Enabled Drug Delivery for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2617631846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617631846?lang=en_us&edition=fundamental","pubTime":"2026-03-07 00:00","pubTimestamp":1772812845,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences Inc. released an investor presentation outlining its Pressure Enabled Drug Delivery platform and the TriNav infusion system portfolio for vascular access outside the heart and brain, with a focus on interventional radiology procedures such as liver embolization. The presentation describes product development and commercialization plans, including an estimated first-half 2026 launch for TriNav Advance, which is pending 510 clearance. The company also highlights U.S. market sizing for Pressure Enabled Drug Delivery applications totaling an estimated 2.5 billion dollars annually across indications including liver tumors, multinodular goiter, uterine fibroid embolization, genicular artery embolization, prostate embolization, and locally advanced pancreas. In addition, the presentation summarizes reimbursement coding and rates for procedures using the TriNav system, including HCPCS codes C8004 and C9797 with 2026 reimbursement rates listed. You can access the full pre","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL6L7Z9T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2617820576","title":"TriSalus Life Sciences price target lowered to $7 from $12 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2617820576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617820576?lang=en_us&edition=fundamental","pubTime":"2026-03-06 19:55","pubTimestamp":1772798111,"startTime":"0","endTime":"0","summary":"Canaccord analyst William Plovanic lowered the firm’s price target on TriSalus Life Sciences (TLSI) to $7 from $12 and keeps a Buy rating on the sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trisalus-life-sciences-price-target-lowered-to-7-from-12-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trisalus-life-sciences-price-target-lowered-to-7-from-12-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2617751065","title":"TriSalus posts Q4 revenue of USD 13.2 million up 60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617751065","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617751065?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:02","pubTimestamp":1772744520,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences reported Q4 2025 revenue of USD 13.2 million, up 60.0% year over year, with gross margin of 86.7% and net loss of USD 9.8 million. Adjusted EBITDA loss narrowed to USD 0.9 million. For FY 2025, revenue was USD 45.2 million, up 53.0%, with net loss attributable to common stockholders of USD 69.7 million and adjusted EBITDA loss of USD 17.2 million; cash and cash equivalents were USD 20.4 million as of Dec. 31, 2025. The company reaffirmed FY 2026 revenue guidance of USD 60 million to USD 62 million, and said it raised USD 46 million in gross proceeds in a post-quarter public offering to support growth initiatives. Business updates included the launch of the TriNav XP Infusion System, continued expansion of TriNav adoption in liver embolization and development of new applications beyond the liver, and the appointment of Michael Stansky to the board in February 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL65qDwm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2617972575","title":"TriSalus Life Sciences Q4 Income From Operations USD -3.271 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2617972575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617972575?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:01","pubTimestamp":1772744460,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nPLX4EA15F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2617940575","title":"Press Release: TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2617940575","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617940575?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:01","pubTimestamp":1772744460,"startTime":"0","endTime":"0","summary":"Reports $13.2 million i n Revenue in the Fourth Quarter, $45.2 million for Full-Year of 2025, Representing increases of 60% and 53%, respectively, Versus the Prior Year Periods. Hosting Conference Call and Webcast today at 4:30pm ET. \"During our fourth quarter and throughout 2025, we continued to deliver strong commercial performance, supported by the growing clinical adoption of our TriNav product suite and proprietary PEDD platform across a broad range of solid tumor indications,\" said Mary Szela, President and CEO of TriSalus. \"We are pleased to have exceeded our 2025 revenue guidance of 50%, delivering 53%, reflecting strong commercial execution and sustained progress on our strategic initiatives, including expansion of the TriNav platform across multiple indications beyond the liver.\". Highlights for Fourth Quarter 2025 and Recent Weeks. and sequential growth of 14% over the third quarter 2025.--  Delivered another strong commercial performance, with expanding use of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4588","BK4022","BK4555","BK4099","TM","R","BK4139","BK4232","TLSI","BK4585","03160"],"gpt_icon":0},{"id":"2616374088","title":"TriSalus Life Sciences Inc  expected to post a loss of 13 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2616374088","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616374088?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:38","pubTimestamp":1772573887,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences Inc  expected to post a loss of13cents a share - Earnings Preview TriSalus Life Sciences Inc TLSI.OQ TLSI.O is expected to  show a rise in quarterly revenue when it reports  res","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL8N3ZR35V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2616321519","title":"Lake Street Sticks to Its Buy Rating for TriSalus Life Sciences (TLSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616321519","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616321519?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:46","pubTimestamp":1772549183,"startTime":"0","endTime":"0","summary":"Lake Street analyst Frank Takkinen reiterated a Buy rating on TriSalus Life Sciences today and set a price target of $10.00. According to TipRanks,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-sticks-to-its-buy-rating-for-trisalus-life-sciences-tlsi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-sticks-to-its-buy-rating-for-trisalus-life-sciences-tlsi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSI"],"gpt_icon":0},{"id":"2614159056","title":"TriSalus Life Sciences Inc. to Host Fourth Quarter Financial Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2614159056","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614159056?lang=en_us&edition=fundamental","pubTime":"2026-02-26 05:11","pubTimestamp":1772053888,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences will report fourth quarter 2025 financial results via a press release issued before its results conference call and webcast on March 5, 2026 at 4:30 PM ET. Phone participants can register via the online form, and the live webcast will be available in the investor relations section of the company’s website.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL62jG04:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2614038525","title":"Lake Street Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614038525","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614038525?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:55","pubTimestamp":1772027731,"startTime":"0","endTime":"0","summary":"Lake Street analyst Frank Takkinen reiterated a Buy rating on TriSalus Life Sciences today and set a price target of $10.00. According to TipRanks,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-reaffirms-their-buy-rating-on-trisalus-life-sciences-tlsi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-reaffirms-their-buy-rating-on-trisalus-life-sciences-tlsi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSI"],"gpt_icon":0},{"id":"2613373710","title":"TriSalus Life Sciences Director Michael P Stansky Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2613373710","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613373710?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:08","pubTimestamp":1771880932,"startTime":"0","endTime":"0","summary":"Michael P. Stansky, a director of TriSalus Life Sciences, Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trisalus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL6hkrFZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TriSalus Life Sciences Director Michael P Stansky Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2612326222","title":"TriSalus Life Sciences Prices Stock Offering at $4.10 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2612326222","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612326222?lang=en_us&edition=fundamental","pubTime":"2026-02-20 21:29","pubTimestamp":1771594168,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences  said Friday it has priced an underwritten public offering of almost 9.8 million shares at $4.10 per share, for expected gross proceeds of about $40 million.The oncology-focused medical technology company also said it has granted the underwriter a 30-day option to buy up to 1,463,415 additional shares.The offering is expected to close around Monday, the company said.Shares of TriSalus were down more than 4% in recent premarket activity Friday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2612264010","title":"TriSalus Life Sciences Inc - Prices Public Offering at $4.10 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2612264010","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612264010?lang=en_us&edition=fundamental","pubTime":"2026-02-20 21:00","pubTimestamp":1771592401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nTUA8WWVB1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2612238858","title":"TriSalus Life Sciences Proposes Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2612238858","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612238858?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:01","pubTimestamp":1771534882,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nFWN3ZF0LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2610896049","title":"TriSalus Life Sciences Inc. Files Initial Statement of Beneficial Ownership for Director Michael P. Stansky","url":"https://stock-news.laohu8.com/highlight/detail?id=2610896049","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610896049?lang=en_us&edition=fundamental","pubTime":"2026-02-12 07:50","pubTimestamp":1770853837,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing names Michael P. Stansky as the beneficial owner, who has been appointed as a director of the company effective February 4, 2026. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trisalus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 11, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDLbQvYgw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"TriSalus Life Sciences Inc. Files Initial Statement of Beneficial Ownership for Director Michael P. Stansky","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2610659514","title":"BRIEF-Trisalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky To Its Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2610659514","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610659514?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:36","pubTimestamp":1770647800,"startTime":"0","endTime":"0","summary":"BRIEF-Trisalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky To Its Board Of DirectorsFeb 9 (Reuters) - TriSalus Life Sciences Inc TLSI.O:TRISALUS LIFE SCIENCES APPOINTS VETERAN H","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUA9K4SCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}]}}